Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study | Zendy

Derya Köseoğlu | Zendy; Salih Süha Koparal | Zendy; Özden Özdemir Başer | Zendy; Dilek Berker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study

Author(s) -

Derya Köseoğlu,

Salih Süha Koparal,

Özden Özdemir Başer,

Dilek Berker

Publication year - 2020

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-2004-154

Subject(s) - medicine , exenatide , nonalcoholic fatty liver disease , lipid profile , type 2 diabetes mellitus , gastroenterology , diabetes mellitus , body mass index , endocrinology , type 2 diabetes , fatty liver , disease

The aim of this study was to evaluate the effects of a 6-month treatment regimen with exenatide on the lipid profile, high-sensitivity C-reactive protein (hsCRP), carotid intima media thickness (CIMT), visceral adiposity, and nonalcoholic fatty liver disease (NAFLD), all of which are important cardiovascular risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research